SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Claros Mortgage Trust disclosed Q2 2026 quarterly financial results (quarter ended June 30, 2026) via press release, reporting a GAAP net loss of $255.4 million ($1.81 per share) and distributable loss of $90.8 million ($0.63 per share), along with detailed financial metrics including loan portfolio composition, REO assets, liquidity, and leverage ratios.
View raw filing on EDGAR →LSB Industries issued a press release on July 29, 2026 reporting financial results for Q2 2026 ended June 30, 2026. The disclosure includes net sales of $168.1M, net loss of $6.2M (including $28.8M turnaround expenses), diluted loss per share of $0.09, and adjusted EBITDA of $53.1M, along with detailed segment performance, balance sheet data, and forward guidance. This is a standard quarterly earnings release attached as Exhibit 99.1 and disclosed under Item 2.02.
View raw filing on EDGAR →Adaptive Biotechnologies disclosed Q2 2026 financial results (quarter ended June 30, 2026) via press release, reporting revenue of $71.6 million, net loss of $39.9 million, and updated full-year MRD revenue guidance to $268–$278 million, with clonoSEQ test volume growth of 43%.
View raw filing on EDGAR →Dr. Harlan Robins, Chief Scientific Officer and Co-founder, transitioned out of his executive officer role into a strategic consultant position, representing a material change in executive leadership.
View raw filing on EDGAR →Arxis issued a press release on July 29, 2026 announcing unaudited financial results for Q2 2026 ended June 30, 2026, disclosing revenue of $501 million (up 25%), net loss of $(5) million (improved from $(29) million), and raising full-year 2026 guidance. The filing explicitly states this is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The disclosure includes detailed quarterly comparisons, segment performance, and forward guidance, all hallmarks of a quarterly earnings announcement.
View raw filing on EDGAR →MAA issued a press release on July 29, 2026 announcing consolidated results of operations and financial condition for the three and six months ended June 30, 2026, including earnings per diluted common share ($1.04 for Q2 2026), Core FFO per share ($2.08), and updated 2026 full-year guidance. The disclosure includes detailed financial highlights, consolidated statements of operations, balance sheet data, and Same Store operating results—all hallmarks of a quarterly earnings release under Item 2.02.
View raw filing on EDGAR →Moelis & Company disclosed second quarter and first half 2026 financial results, reporting record Q2 revenues of $409.4 million (up 12% YoY) and H1 2026 revenues of $729.2 million (up 9% YoY), along with GAAP diluted EPS of $0.62 and $1.10 respectively, and a declared quarterly dividend of $0.65 per share.
View raw filing on EDGAR →Equifax issued $1 billion in aggregate principal amount of senior notes ($500M due 2029 at 5.000% and $500M due 2033 at 5.650%), creating a direct financial obligation. The disclosure details the underwriting agreement, indenture terms, interest rates, maturity dates, and redemption provisions. Net proceeds of approximately $990.5 million are intended for repayment of commercial paper borrowings. This is a material debt issuance under Item 2.03 (or Item 8.01 as filed here).
View raw filing on EDGAR →GBank Financial Holdings Inc. issued a press release on July 29, 2026 announcing its second quarter 2026 financial results, including net income of $5.5 million ($0.38 per diluted share) and net revenue of $22.0 million (a record quarter), along with detailed balance sheet and asset quality metrics.
View raw filing on EDGAR →Jeffrey E. Whicker separated from his positions as Executive Vice President and Chief Financial Officer on July 24, 2026, and is entitled to severance benefits including twelve months of continued base salary and benefit plan participation under his Employment Agreement.
View raw filing on EDGAR →This is a standard quarterly earnings release for Q2 2026 (quarter ended June 30, 2026) filed on July 29, 2026. The Item 2.02 disclosure announces financial and operating results including production volumes (113.1 Bcfe), revenues ($331.6 million in natural gas and oil sales), net income ($8.8 million or $0.03 per diluted share), and cash flows from operations ($170.2 million), with detailed financial statements and non-GAAP reconciliations attached as Exhibit 99.1. This is a material disclosure affecting investor assessment of the registrant's financial performance.
View raw filing on EDGAR →This is a standard earnings release disclosing Q2 2026 financial results for Impinj, Inc., filed under Item 2.02 (Results of Operations and Financial Condition). The press release titled "Impinj Reports Second Quarter 2026 Financial Results" is attached as Exhibit 99.1 and reports revenue of $108.4 million, GAAP net income of $12.2 million, and adjusted EBITDA of $30.7 million, along with Q3 2026 guidance. Earnings releases are material to investors as they provide core financial performance data.
View raw filing on EDGAR →John E. Schlifske retired from the Board and stepped down as independent Chair of the Board effective July 28, 2026, after nearly 15 years of service.
View raw filing on EDGAR →First US Bancshares issued a press release on July 29, 2026 announcing quarterly financial results for the period ended June 30, 2026, disclosing net income of $1.8 million ($0.31 per diluted share) and comprehensive financial metrics. This is a standard earnings release filed under Item 2.02 and attached as Exhibit 99.1, which is the typical disclosure mechanism for quarterly results.
View raw filing on EDGAR →Ryerson disclosed its second quarter 2026 financial results via press release on July 29, 2026, reporting revenue of $2.01 billion, net income of $15.5 million ($0.30 per share), and Adjusted EBITDA excluding LIFO of $101.0 million, with forward guidance for Q3 2026.
View raw filing on EDGAR →The Board of Directors declared a quarterly cash dividend of $0.1875 per share of common stock, payable on September 17, 2026, to stockholders of record as of September 3, 2026.
View raw filing on EDGAR →Regency Centers issued its second quarter 2026 earnings release on July 29, 2026, reporting net income of $0.61 per diluted share, Nareit FFO of $1.21 per diluted share, same property NOI growth of 3.8%, and updated full-year 2026 guidance with raised FFO and core operating earnings ranges.
View raw filing on EDGAR →Procore Technologies entered into a definitive Agreement and Plan of Merger on July 27, 2026, to acquire DroneDeploy, Inc. for approximately $845 million in cash, with a $700 million debt financing commitment and closing conditions including regulatory approvals and stockholder adoption.
View raw filing on EDGAR →ACRES Commercial Realty Corp. disclosed second quarter 2026 operating results on July 29, 2026, reporting a GAAP net loss of $12.5 million or $(1.87) per share-diluted, along with CRE loan portfolio metrics and liquidity position details in a press release and earnings presentation.
View raw filing on EDGAR →Hexcel Corporation issued its Q2 2026 earnings release on July 29, 2026, reporting net sales of $529.3 million (8.0% increase year-over-year), GAAP diluted EPS of $0.64 versus $0.17 in Q2 2025, and adjusted diluted EPS of $0.66 versus $0.50. The company raised its full-year 2026 guidance for both sales ($2.025–$2.125 billion) and adjusted EPS ($2.30–$2.40).
View raw filing on EDGAR →Private Bancorp of America announced that its Form 10 Registration Statement was declared effective by the SEC and that its common stock has been approved for listing on the Nasdaq Global Select Market, with trading commencing July 30, 2026 under ticker "PBAM." This is an uplisting from the OTCQX market after 13+ years. While this is a significant corporate milestone affecting market visibility, liquidity, and capital access, it does not fit the specific event types in the taxonomy (not M&A, not a governance change, not a financial obligation). The event is clearly operational/strategic in nature and material to investors, making `operational_other` the most appropriate classification.
View raw filing on EDGAR →This is a clear earnings release disclosing Amarin's financial results for Q2 2026 and the first half of 2026, including total net revenue of $42.2 million (Q2) and $87.3 million (1H), operating loss, net loss, cash position, and forward-looking guidance. The press release is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures. The filing includes detailed financial tables, operational highlights, and management commentary on performance and outlook.
View raw filing on EDGAR →This is a clear earnings release for Q2 2026 (ended June 30, 2026) filed on July 29, 2026. The Item 2.02 disclosure explicitly states that "financial information for Magnachip Semiconductor Corporation and its consolidated subsidiaries for the second quarter ended June 30, 2026, as presented in a press release dated July 29, 2026" is attached as Exhibit 99.1. The exhibit contains consolidated statements of operations, balance sheets, cash flows, and detailed financial metrics including revenue ($44.7M), gross profit margin (19.3%), operating loss, and EPS data, along with Q3 2026 guidance. This is material to investors as it discloses quarterly financial performance and forward guidance.
View raw filing on EDGAR →Dyne Therapeutics issued a press release on July 29, 2026 announcing financial results for the quarter ended June 30, 2026, including R&D expenses of $152.2 million, G&A expenses of $29.5 million, and a net loss of $178.6 million ($1.08 per share). The press release is furnished as Exhibit 99.1 and discloses quarterly operating results, cash position, and financial metrics typical of an earnings release under Item 2.02.
View raw filing on EDGAR →Core Laboratories issued a press release on July 29, 2026, announcing its second quarter 2026 financial results, including revenue of $124.6 million, operating income of $9.2 million, and EPS of $0.13, along with detailed segment performance, cash flow metrics, and Q3 2026 guidance.
View raw filing on EDGAR →PennyMac Mortgage Investment Trust issued a press release on July 29, 2026 announcing financial results for the second quarter ended June 30, 2026, disclosing net income attributable to common shareholders of $20 million ($0.23 per diluted share), net investment income of $73 million, and an annualized return on common equity of 6%. The filing explicitly states the press release and slide presentation were "announcing its financial results for the fiscal quarter ended June 30, 2026" and are furnished as exhibits, which is the standard form of quarterly earnings disclosure under Item 2.02.
View raw filing on EDGAR →The filing discloses a material litigation development: dismissal of two major antitrust lawsuits against Westlake in the Netherlands and Germany, including one by Shell Chemical Europe alleging approximately €1,025 million in damages. Although the dismissals are favorable to the Company, they remain subject to appeal and twelve related lawsuits are still pending, making this a significant material litigation event affecting investor assessment of the Company's legal exposure and contingent liabilities.
View raw filing on EDGAR →This is a clear earnings release for Q2 2026 (quarter ended June 30, 2026) filed on July 29, 2026. The Item 2.02 disclosure announces quarterly financial results including revenue of $756 million (up 18% YoY), diluted GAAP EPS of $0.55, and raises full-year fiscal 2026 revenue guidance to a record $3 billion. The press release and investor presentation are attached as Exhibits 99.1 and 99.2, which is the standard format for earnings disclosures under Item 2.02.
View raw filing on EDGAR →Isabelle Courville, Chair of the Board since May 2019, retired from the Board effective immediately on July 29, 2026. While the filing also discloses the appointment of Gordon Trafton as the new Chair, the principal disclosed action centers on Courville's departure from this senior leadership position.
View raw filing on EDGAR →Four Corners Property Trust disclosed its financial results for the quarter ended June 30, 2026, reporting rental revenue of $70.0 million (8.0% growth), net income of $30.0 million ($0.27 per diluted share), and AFFO per share of $0.45, along with an investor presentation and detailed operating metrics.
View raw filing on EDGAR →The Company drew an additional $1.5 million under an existing revolving credit facility on July 28, 2026. While the underlying Loan Agreement was previously disclosed on April 21, 2026, this Item 2.03 disclosure addresses the creation of a new direct financial obligation through the incremental draw. The filing explicitly states the Company "received and borrowed an additional draw" and references Item 2.03 (Creation of a Direct Financial Obligation), which is the standard Item for debt issuances and credit facility draws.
View raw filing on EDGAR →DIRTT Environmental Solutions issued a press release on July 29, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing Q2 2026 revenue of $40.3 million (4% increase YoY), net income of $1.1 million (vs. $6.6 million loss in Q2 2025), and updated 2026 full-year guidance of $175.0–$185.0 million revenue and $21.0–$25.0 million Adjusted EBITDA. This is a standard quarterly earnings release filed under Item 2.02 with the press release furnished as Exhibit 99.1.
View raw filing on EDGAR →TechTarget issued a press release on July 29, 2026 providing a half-year business update ahead of Informa PLC's consolidated results. The release discloses specific financial metrics for H1 2026: revenue of £165.0 million (down from £171.6 million in H1 2025), underlying revenue growth of -1.3%, Adjusted Operating Profit of £4.7 million, and Statutory Operating Loss of £41.2 million. This is a periodic financial results disclosure furnished under Item 2.02, meeting the definition of an earnings release.
View raw filing on EDGAR →The disclosure centers on amendments to executive employment agreements for three named officers (Troy E. Wilson, Ph.D., J.D., Brian Powl, and Kathleen Ford) that modify severance provisions, including cash payments, equity acceleration, and COBRA continuation benefits triggered by termination or resignation events, particularly in connection with a Corporate Transaction. This is a classic compensatory arrangement disclosure under Item 5.02(e).
View raw filing on EDGAR →Serhii Kupriienko resigned as Chief Executive Officer (Global) effective immediately on July 26, 2026. This is a clear departure of a named executive officer from a senior leadership position. While the filing notes that Alexander Fink will continue as principal executive officer and no successor will be appointed to the Global CEO role, the principal disclosed action is Kupriienko's resignation from his executive position.
View raw filing on EDGAR →Chad Roberts, Executive Vice President of Production Solutions, gave notice of his intent to resign effective August 3, 2026. The disclosure centers on the departure of a named executive officer, making this a clear exec_departure event. The resignation of an EVP is material to investors as it affects the company's leadership and operational continuity.
View raw filing on EDGAR →The filing discloses unauthorized access to Company systems on June 23, 2026, with exfiltration of certain files, immediate activation of incident response protocols, engagement of external cybersecurity experts, and coordination with law enforcement. Although the Company states it does not currently believe the incident is reasonably likely to materially impact business operations or financial condition, the disclosure of unauthorized access, data exfiltration, and ongoing investigation into the scope of compromised information constitutes a material cybersecurity incident under Item 1.05 (required since 2023) and Item 8.01 (Other Events). The filing also references a separate, unrelated cybersecurity matter under assessment.
View raw filing on EDGAR →The filing discloses an unregistered sale of approximately 1.5 million common units for $29.7 million pursuant to subscription agreements with existing unitholders, relying on Section 4(a)(2) and Regulation D exemptions. This is a classic dilutive issuance of equity securities to accredited investors under a capital drawdown mechanism, material to investors as it represents a significant capital raise and dilution event for the fund.
View raw filing on EDGAR →The filing discloses the appointment of two new directors, Sharon L. O'Keefe and Thomas A. West, to the Board effective July 28, 2026, following an increase in authorized board size from seven to nine directors. While the section also mentions reclassifications of existing directors Burke and Taylor for rebalancing purposes, the principal disclosed action centers on the election of two new directors with specified committee assignments and compensation arrangements. This is material as it represents a change in board composition and governance structure.
View raw filing on EDGAR →This is a news release announcing Silicon Motion's financial results for the quarterly period ended June 30, 2026 (Q2 2026). The exhibit discloses net sales of $451.0 million (+32% Q/Q, +127% Y/Y), net income (GAAP) of $136.1 million ($3.99 per diluted ADS), and detailed financial statements including consolidated income statements, balance sheets, and cash flow statements. The company also provides forward guidance for Q3 2026 revenue of $519–$541 million. This is a classic earnings release event material to investors assessing the registrant's financial performance and trajectory.
View raw filing on EDGAR →Galaxy Gaming amended its existing Credit Agreement with BMO Bank N.A. on July 24, 2026, modifying key financial covenants including the Fixed Charge Coverage Ratio and reporting requirements. The amendment materially restructures the credit facility's terms, including allowance for a $4 million share repurchase contingent on maintaining $5 million in unencumbered liquid assets and covenant compliance, affecting the company's financial flexibility and obligations.
View raw filing on EDGAR →TNL Mediagene and 3i, LP mutually terminated a securities purchase agreement dated November 25, 2024 (as amended December 8, 2025), extinguishing all obligations under the original agreement including rights to Subsequent Closing, Additional Notes and Warrants. The termination preserves the 3i Warrant and grants 3i a one-year pro-rata participation right in future financings, representing a restructuring of the investment relationship rather than a complete dissolution.
View raw filing on EDGAR →TNL Mediagene announced the full repayment and termination of its senior convertible note facility with 3i, LP, eliminating convertible-instrument dilution and overhang while simplifying the capital structure for the recently public company.
View raw filing on EDGAR →The filing discloses material developments in an ongoing business combination between Inflection Point Acquisition Corp. III and Air Water Ventures Holdings Limited. The core disclosure concerns a service provider agreement tied to the Business Combination's redemption mechanics and reports that as of July 27, 2026, Inflection Point had received redemption requests for 24,673,661 Class A shares—a substantial portion of the SPAC's capitalization. This redemption activity is directly material to the consummation and economics of the Business Combination, making this an M&A activity disclosure under Item 8.01.
View raw filing on EDGAR →The filing discloses termination of a Securities Purchase Agreement for issuance of Series AA and Series B Convertible Preferred Stock, which constitutes a material capital transaction. Although the termination was initiated by the lead investor citing alleged breaches, the Company disputes the termination and is evaluating its legal remedies, indicating the transaction was material to the Company's financing plans. The disclosure of a failed or terminated material definitive agreement under Item 1.02 is a core M&A/capital activity event.
View raw filing on EDGAR →Healthcare Triangle issued 12,546,540 unregistered shares of common stock on July 28, 2026, comprising 9,718,373 shares to Teyame AI LLC entities and 2,828,167 shares to SecureKloud Technologies Ltd. counterparties, both in reliance on Section 4(a)(2) and Regulation D exemptions. This represents a substantial dilutive issuance that increased outstanding shares from approximately 2.1 million to 14.6 million—a material capital event disclosed under Item 3.02 and explicitly highlighted in the press release as strengthening the company's Nasdaq listing compliance position.
View raw filing on EDGAR →The 6-K discloses results of an Extraordinary General Meeting of Shareholders held on July 29, 2026, at which shareholders approved a proposal brought before them. While the specific proposal details are referenced in a prior July 7, 2026 filing (Exhibit 99.1), this report furnishes the vote results and approval outcome, which is the hallmark of shareholder_vote_results disclosure. The materiality is supported by the fact that an extraordinary meeting was convened and shareholder approval was required, indicating a significant corporate action.
View raw filing on EDGAR →CleanCore entered into a Contribution Agreement, LLC Agreement, Development Services Agreement, and Software License Agreement on July 23, 2026 to form a joint venture (Monarch SPV HoldCo LLC) for financing, developing, and operating a 55 MW data center facility in Minnesota. The Company holds 79% ownership and will contribute up to $500 million in capital. This constitutes entry into a material definitive agreement creating a significant new business venture with substantial capital commitment and long-term revenue potential ($800 million initial contract value with Cerebras, expandable to $3+ billion with renewal options), disclosed under Item 1.01.
View raw filing on EDGAR →The Board appointed Kimberly Hawley as Interim Chief Financial Officer effective July 6, 2026, with an employment agreement providing $250,000 annual base salary and a $50,000 restricted stock grant. While the disclosure includes compensatory details, the principal disclosed action is the appointment of a named executive to a C-suite officer role, making this an executive appointment event. The appointment of an interim CFO is material to investors assessing the company's financial leadership and governance.
View raw filing on EDGAR →PolyPid announced FDA acceptance of its NDA for D-PLEX100 with Priority Review status and an accelerated PDUFA target action date of November 28, 2026. This is a material regulatory milestone that triggers a $15 million milestone payment from commercial partner Azurity and represents significant progress toward potential market approval. While this is a regulatory/operational event rather than a discrete financial event (earnings, debt, M&A), it materially affects investor assessment of the company's development trajectory and near-term commercialization prospects.
View raw filing on EDGAR →